International Journal of Hospital Pharmacy

Summary of the Clinical Pharmacist’s Role in the Management of Acute Pancreatitis: A Clinical Review

Review Article of International Journal of Hospital Pharmacy Summary of the Clinical Pharmacist’s Role in the Management of Acute Pancreatitis: A Clinical Review Jad El Tom1, Alisar Serhan2, Tarek Safi3, Wissam K Kabbara4 1School of Pharmacy, Lebanese American University (LAU), Byblos, Lebanon; 2Hospital Pharmacist, Saint George Hospital University Medical Center, Beirut, Lebanon;3Saarland University Medical Center, Homburg, Germany; 4Clinical Associate Professor, Department of Pharmacy Practice, School of Pharmacy, Lebanese American University (LAU), Byblos, Lebanon. Introduction: The role of the clinical pharmacist in the management of acute pancreatitis has not been researched extensively, and only a few published studies on the topic can be found. This clinical review presents all pertinent published data and serves as a guide for clinical pharmacists who participate in the management of patients with acute pancreatitis. Methods: An extensive literature search was conducted on PubMed from 1990 to 2021 to retrieve relevant studies focusing on the role of the clinical pharmacist in the treatment of acute pancreatitis. Results: An analysis of the medications that are associated with acute pancreatitis is presented, highlighting the responsibility of the pharmacist to conduct a thorough medication investigation in order to identify a possible drug-induced acute pancreatitis. Medical management of acute pancreatitis, mainly fluid therapy, is an area where a clinical pharmacist can appropriately intervene. Proper choice of fluid therapy and its rate, nutritional considerations, pain management and antibiotic use, are all important to consider for a successful treatment with minimal adverse effects. It is well documented in the literature that clinical pharmacists can decrease hospital costs. Discharge counseling performed by a clinical pharmacist has been shown to increase patient compliance and decrease both readmission rates and follow-up physician visits. Conclusion: The clinical pharmacist, as the primary drug expert, can identify medication-induced pancreatitis, diminish the use of unnecessary antibiotics, improve patient care ...

Antibotics Which Distrbuted in the Hospital of Al Wahda (Derna, Libya) by Medical Supply Ward for 3 Months and Their Relations With Number of Patients Admitted and Compare These Antibiotics With Bacterial Culture Results Done by Laboratory

Research Article of International Journal of Hospital Pharmacy Antibotics Which Distrbuted in the Hospital of Al Wahda (Derna, Libya) by Medical Supply Ward for 3 Months and Their Relations With Number of Patients Admitted and Compare These Antibiotics With Bacterial Culture Results Done by Laboratory Mahmoud El Mabri1, Abduljaleel el-shalwi2, Bilal B Rafadi3 1Medical Supply Ward Wahda Hospital, Faculty of Pharmacy. Benghazi University, Derna Libya; 2Medical Supply Ward Wahda Hospital, Faculty of Pharmacy. Omar Elmokhtar University; 3Benghazi University, Derna Libya Antimicrobial resistance (and particularly antibiotic resistance) is spreading now, and there are few prospects for the development of new classes of antibiotics in the short term. However, there is today considerable awareness of the need for, and political support for, action to combat Antimicrobial resistance1. Surveillance of antimicrobial use tracks how and why antimicrobials are being used and misused by patients and healthcare providers. Monitoring antimicrobial prescription and consumption behavior provides insights and tools needed to inform therapy decisions, to assess the public health consequences of antimicrobial misuse, and to evaluate the impact resistance containment interventions2. And all reports from WHO tell us about post antibiotics era that will be start if we don’t work quickly on antibiotics resistance by all efforts and due to situations of my country in Libya now need a lot of studies to decrease corruption in budgets put for health sector. Experimental methods: Study made by pilot method and we depend on data collected from dispensing papers of medical supply ward in Al Wahda hospital. *medical statistics office of Al Wahda hospital *Al Wahda hospital laboratory. *data collected to 3 months and 477 in- patient of wahda hospital. Results and discussion: After collect data from dispensing paper that based on treatment chart, we covered 477 patients for 3 months by 2169 ceftri-702 gent-1360 aug-547 cefot-23amik ...

PASS Protocol Fever as basis of COVID-19 testing in Patient- A Union Therapy Initiative

Review Article of International Journal of Hospital Pharmacy PASS Protocol Fever as basis of COVID-19 testing in Patient- A Union Therapy Initiative Kanishk Kala, Rupinder Kaur Sodhi IK Gujral PTU Fever is the sole symptomatic measurement modality for Covid-19 screening which could be implemented easily all over the globe in with optimal utilization of resources. Being easy economical and easily reproducible, this has a potential to be a gold standard as well as simplicity of the procedure could help in its monitoring by patients itself and would operate an important element of patient involvement in treatment and would help in adherence in countries where health care staff are short and patient burden is high. This protocol will extend helping hands to health care worker and will involve patient participation in the treatment also. Keywords:COVID -19 , fever , Union Therapy , PASS protocol , Sayojya Chikitsa ...

Guidelines for Safe and Effective Use of Hydroxychloroquine in COVID-19 Patients

Review Article of International Journal of Hospital Pharmacy Guidelines for Safe and Effective Use of Hydroxychloroquine in COVID-19 Patients Hannah Ariel Department of Chemistry and Biochemistry, Queens College The emergent need to treat COVID-19 patient must be tempered with safe use of drugs. The guideline set forth provides parameters for dosing and monitoring hydroxychloroquine in this population, reducing the occurrence of adverse effects and improving overall pharmacotherapy. Keywords: Hydroxychloroquine, COVID-19 Patients, Safe and Effective Use ...

Dr. Fadi Alkhateeb Professor

Vice Editor-in-Chief:
Dr. Saurabh Gupta Professor and Head


Dr. Mohammed A. Islam
Department of Pharmaceutical Sciences, West Coast University School of Pharmacy, Los Angeles, CA, USA.

Dr. Juseop Kang
Department of Pharmacology and Clinical Pharmacology Laboratory, College of Medicine, Hanyang University, Seoul 133-791, South Korea.

Dr. Mohamed Azmi Hassali
Professor of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.

Dr. Apollo James
Department of Pharmacy Practice, Nandha college of Pharmacy, Erode, Tamilnadu, India.

Dr. Iftikhar Ali
Department of Pharmacy, Northwest General Hospital and Research Center, Department of Pharmacy, University of Swabi, Khyber Pakhtunkhwa , Pakistan.

Dr Anthony David Hall
School of Clinical Sciences, Queensland University of Technology (QUT), Brisbane, Australia.

Dr Bhanukumar M
Department of General Medicine, JSS Hospital & Medical College, JSS University, Mysore, India.

Dr. Sandeep Kumar Kar
Institute of Postgraduate Medical Education & Research, India.

Dr. Biswaranjan Paital
Department of Zoology, Orissa University of Agriculture and Technology, College of Basic Science and Humanities, Bhubaneswar-751003, Odisha, India.

Dr. Vasiliki E. Kalodimou
Director at Flow Cytometry-Research & Regenerative Medicine Department, Athens, Greece.

Dr. Hale Z. Toklu
Department of Pharmacology & Therapeutics, University of Florida College of Medicine, 32610 Gainesville, FL, USA.

Dr. Fahad Saleem
Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains, Malaysia, Minden 11800, Penang, Malaysia

Dr. Ahamada Safna Mariyam.M
Dept of Pharmacy Practice, Acharya & B.M Reddy College of Pharmacy, Bangalore-107, India.

Dr. Ghada Ismail El Shahat Ali Attia
Literature of Pharmacognosy, Departments of Pharmacognosy, Faculty of Pharmacy, TANTA University- Egypt

Dr. Tauqeer Hussain Mallhi
School Of Pharmaceutical Sciences, Usm, Penang, Malaysia

Dr. Burton M. Altura

Physiology and Pharmacology Department, SUNY Downstate Medical Center, NY, USA.

Dr.  Yousif Abdu Asiri
Vice – Rector for Planning and Development, Professor of Clinical Pharmacy, King Saud University,, Riyadh 11451, Saudi Arabia.

Dr. Amit K. Tiwari
Department of Pharmacology & Experimental Therapeutics, The University of Toledo – Health Science Campus, Toledo, OH, USA.

Dr. Saurabh Gupta
Professor and Head, Department of Pharmacology, Indore Institute of Pharmacy, Indore (M.P.), India, Principal Co-ordinator Scientist for outsources projects of industry, Indore institute of Pharmacy, Indore (M.P.), India, Scientist Co-ordinator member of Institutional Animal Ethical Committee, Indore institute of Pharmacy, Indore.

Dr. Tyler Madere
University of North Texas System College of Pharmacy –Department of Pharmacotherapy, Fort Worth, TX,USA.

Dr. Xianquan Zhan
Professor and Deputy Director, Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China

Dr. Fatima Suleman
Head of Discipline of Pharmaceutical Sciences, School of Health Sciences, College of Health Sciences of University of KwaZulu-Natal, Durban, South Africa.

Dr. Mohamed Eddouks
Faculty of Sciences and Techniques Errachidia, Moulay Ismail University, Meknes, Morocco.

Dr.  Syed A. A. Rizvi 
Department of Pharmaceutical Sciences, College of Pharmacy, Health Professions Division, Nova Southeastern University, FL, USA.

Dr. Carmela Saturnino 
Faculty of Pharmacy, University of Salerno, SA, ITALY.

Dr. Taha Nazir
University of Sargodha, Sargodha 40100, Pakistan.

Dr. Fadi Alkhateeb
Pharmacy Administration, Department of Pharmacy Practice, Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas, USA.

Dr. Madhan Ramesh
Professor & Head, Department of Pharmacy Practice, JSS College of Pharmacy, JSS University, S S Nagar, Mysore.

Sushanta Kr. Das.
M. Pharm (Pharmacy Practice), Associate Professor and Pharm D Coordinator, CMR College of Pharmacy, Hyderabad

Dr. Mario Bernardo-Filho
Professor Titular, Universidade do Estado do Rio de Janeiro

Manuscript Title: The title should be a brief phrase.

Author Information: List full names and affiliation of all authors, including Emails and phone numbers of corresponding author.

Abstract: The abstract should be less than 500 words. Following abstract, a list of keywords and abbreviations should be added. The keywords should be no more than 10. Abbreviation are only used for non standard and long terms.

Introduction: The introduction should included a clear statement of current problems.

Materials and Methods: This section should be clearly described.

Results and discussion: Authors may put results and discussion into a single section or show them separately.

Acknowledgement: This section includes a brief acknowledgment of people, grant details, funds

References: References should be listed in a numbered citation order at the end of the manuscript. DOIs and links to referenced articles should be added if available. Abstracts and talks for conferences or papers not yet accepted should not be cited. Examples Published Papers: 

1.Kim P.G.M. Hurkens, Carlota Mestres-Gonzalvo, Hugo A.J.M. de Wit, Rob Janknegt, Frans Verhey, Jos M.G.A. Schols, Fabienne Magdelijns, Coen D.A. Stehouwer, Bjorn Winkens, Wubbo Mulder and P. Hugo M. van der Kuy. Assessing the strengths and weaknesses of a computer assisted medication review in hospitalized patients. International Journal of Hospital Pharmacy, 2017,2:6. DOI: 10.28933/IJHP-2017-10-0101 
2.Ananth kashyap, Rashmi N G, Rakshith U R, Hanumanthachar Joshi.Selective Serotonin Reuptake Inhibitors Induced Serotonin Syndrome –A Case Report. International Journal of Hospital Pharmacy, 2017,2:7. DOI:10.28933/ijhp-2017-10-1101

Tables and figures: Tables should be used at a minimum with a short descriptive title. The preferred file formats for Figures/Graphics are GIF, TIFF, JPEG or PowerPoint.

Proofreading and Publication: A proof will be sent to the corresponding author before publication. Authors should carefully read the proof to avoid any errors and return the proof to the editorial office. Editorial office will publish the article shortly and send a notice to authors with the links of the paper.

Open Access
International Journal of Hospital Pharmacy is a peer reviewed open access journal publishing research manuscripts, review articles, case reports, editorials, letters to the editor in Hospital Pharmacy (indexing details).

Peer Review
To ensure the quality of the publications, all submitted manuscripts will be peer-reviewed by invited experts in the field. The decisions of editors will be made based on the comments of the reviewers.

Rapid Publication
Time to first decision: within 2 days for initial decision without review, 18 days with review; Time to publication: Accepted articles will be published online within 2 days, and final corrected versions by authors will be accessible within 5 days.More details....

Rapid Response Team
Please feel free to contact our rapid response team if you have any questions. Our customer representative will answer you shortly.

International Journal of Hospital Pharmacy